// App-Quantinova.ai

9009 : Evolution and clinical impact of genomic alterations detectable in circulating tumor DNA of 1150 advanced EGFR-mutant (mt) lung cancer patients.

Researchers

Presenter

  • Collin M. Blakely

Principal Investigators

  • Wei Wu

  • Matthew A. Gubens

  • Julia Rotow

  • Victoria Wang

  • Kimberly Banks

  • Richard B. Lanman

  • Philip C. Mack

  • Hatim Husain

  • Caroline Elizabeth McCoach

  • Robert Charles Doebele

  • Jonathan Riess

  • Trever Grant Bivona

Medical Centers

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • Guardant Health, Rewdwood City, CA

  • University of California, Davis Comprehensive Cancer Center, Sacramento, CA

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

  • University of Colorado Denver School of Medicine, Aurora, CO

  • University of Colorado Anschutz Medical Campus, Aurora, CO

  • UC Davis Comprehensive Cancer Center, Sacramento, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved